•
Sep 30, 2021

Summit Therapeutics Q3 2021 Earnings Report

Total Revenue
$1.31M
Previous year: $181K
+623.2%
EPS
-$0.2
Previous year: -$0.26
-23.1%
Gross Profit
$1.31M
Previous year: $181K
+623.2%
Cash and Equivalents
$80.2M
Previous year: $21.3M
+277.3%
Free Cash Flow
-$23.6M
Previous year: -$16.9M
+39.7%
Total Assets
$129M
Previous year: $56.9M
+126.3%

Summit Therapeutics

Summit Therapeutics